Correction to: Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes

Jonathan I Silverberg; Jacob P Thyssen; Eric L Simpson; Gil Yosipovitch; Sonja Ständer; Hernan Valdez; Ricardo Rojo; Pinaki Biswas; Daniela E Myers; Claire Feeney; Marco DiBonaventura

doi:10.1007/s40257-021-00634-3

Correction to: Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes

Jonathan I Silverberg, Jacob P Thyssen, Eric L Simpson, Gil Yosipovitch, Sonja Ständer, Hernan Valdez, Ricardo Rojo, Pinaki Biswas, Daniela E Myers, Claire Feeney, Marco DiBonaventura

Dermato- & Venerologisk Afd.

Abstract

Page 550, Fig. 4: The legend, which previously read: Fig. 4. Impact of treatment on a Dermatology Life Quality Index (DLQI) ^a and b Children’s Dermatology Life Quality Index (CDLQI) ^b band descriptors. ^aFor patients ≥ 8 years of age. ^bFor patients < 18 years of age. Should read: Fig. 4. Impact of treatment on a Dermatology Life Quality Index (DLQI) ^a and b Children’s Dermatology Life Quality Index (CDLQI) ^b band descriptors. ^aFor patients ≥ 18 years of age. ^bFor patients < 18 years of age.

Originalsprog	Engelsk
Publikationsdato	sep. 2021
Udgave	5
Vol/bind	22
Antal sider	1
DOI	https://doi.org/10.1007/s40257-021-00634-3
Status	Udgivet - sep. 2021

Navn	American Journal of Clinical Dermatology
ISSN	1175-0561

Adgang til dokumentet

10.1007/s40257-021-00634-3

Andre filer og links

Link to publication in Scopus

Fingeraftryk

Dyk ned i forskningsemnerne om 'Correction to: Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes'. Sammen danner de et unikt fingeraftryk.

Citationsformater

Silverberg, J. I., Thyssen, J. P., Simpson, E. L., Yosipovitch, G., Ständer, S., Valdez, H., Rojo, R., Biswas, P., Myers, D. E., Feeney, C., & DiBonaventura, M. (2021, sep.). Correction to: Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes. (5 udg.) American Journal of Clinical Dermatology https://doi.org/10.1007/s40257-021-00634-3

Correction to: Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes. / Silverberg, Jonathan I; Thyssen, Jacob P; Simpson, Eric L et al.
1 s. 5 udg. 2021. (American Journal of Clinical Dermatology).

Publikation: Andet › Andet bidrag › Forskning

Silverberg, JI, Thyssen, JP, Simpson, EL, Yosipovitch, G, Ständer, S, Valdez, H, Rojo, R, Biswas, P, Myers, DE, Feeney, C & DiBonaventura, M 2021, Correction to: Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes.. https://doi.org/10.1007/s40257-021-00634-3

@misc{8622d07e74b34e7e98c6a3579e9527a2,

title = "Correction to: Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes",

abstract = "Page 550, Fig. 4: The legend, which previously read: Fig. 4. Impact of treatment on a Dermatology Life Quality Index (DLQI) a and b Children{\textquoteright}s Dermatology Life Quality Index (CDLQI) b band descriptors. aFor patients ≥ 8 years of age. bFor patients < 18 years of age. Should read: Fig. 4. Impact of treatment on a Dermatology Life Quality Index (DLQI) a and b Children{\textquoteright}s Dermatology Life Quality Index (CDLQI) b band descriptors. aFor patients ≥ 18 years of age. bFor patients < 18 years of age. ",

author = "Silverberg, {Jonathan I} and Thyssen, {Jacob P} and Simpson, {Eric L} and Gil Yosipovitch and Sonja St{\"a}nder and Hernan Valdez and Ricardo Rojo and Pinaki Biswas and Myers, {Daniela E} and Claire Feeney and Marco DiBonaventura",

year = "2021",

month = sep,

doi = "10.1007/s40257-021-00634-3",

language = "English",

volume = "22",

series = "American Journal of Clinical Dermatology",

publisher = "Adis",

edition = "5",

type = "Other",

}

TY - GEN

T1 - Correction to

T2 - Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes

AU - Silverberg, Jonathan I

AU - Thyssen, Jacob P

AU - Simpson, Eric L

AU - Yosipovitch, Gil

AU - Ständer, Sonja

AU - Valdez, Hernan

AU - Rojo, Ricardo

AU - Biswas, Pinaki

AU - Myers, Daniela E

AU - Feeney, Claire

AU - DiBonaventura, Marco

PY - 2021/9

Y1 - 2021/9

N2 - Page 550, Fig. 4: The legend, which previously read: Fig. 4. Impact of treatment on a Dermatology Life Quality Index (DLQI) a and b Children’s Dermatology Life Quality Index (CDLQI) b band descriptors. aFor patients ≥ 8 years of age. bFor patients < 18 years of age. Should read: Fig. 4. Impact of treatment on a Dermatology Life Quality Index (DLQI) a and b Children’s Dermatology Life Quality Index (CDLQI) b band descriptors. aFor patients ≥ 18 years of age. bFor patients < 18 years of age.

AB - Page 550, Fig. 4: The legend, which previously read: Fig. 4. Impact of treatment on a Dermatology Life Quality Index (DLQI) a and b Children’s Dermatology Life Quality Index (CDLQI) b band descriptors. aFor patients ≥ 8 years of age. bFor patients < 18 years of age. Should read: Fig. 4. Impact of treatment on a Dermatology Life Quality Index (DLQI) a and b Children’s Dermatology Life Quality Index (CDLQI) b band descriptors. aFor patients ≥ 18 years of age. bFor patients < 18 years of age.

UR - http://www.scopus.com/inward/record.url?scp=85112825822&partnerID=8YFLogxK

U2 - 10.1007/s40257-021-00634-3

DO - 10.1007/s40257-021-00634-3

M3 - Other contribution

C2 - 34406620

VL - 22

T3 - American Journal of Clinical Dermatology

ER -